Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma
- 9 March 2021
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 149 (1) , 228-238
Abstract
Type XI collagen has been associated with tumor fibrosis and aggressiveness in patients with pancreatic ductal adenocarcinoma (PDAC). The propeptide on Type XI collagen is released into the circulation after proteolytic processing at either amino acid 253 or 511. This allows for a noninvasive biomarker approach to quantify Type XI collagen production. We developed two ELISA‐based biomarkers, targeting the two enzymatic cleavage sites (PRO‐C11‐253 and PRO‐C11‐511). In a discovery cohort including serum from patients with PDAC (n = 39, Stages 1‐4), chronic pancreatitis (CP, n = 12) and healthy controls (n = 20), PRO‐C11‐511, but not PRO‐C11‐253, was significantly upregulated in patients with PDAC and CP compared to healthy controls. Furthermore, PRO‐C11‐511 levels >75th percentile were associated with poor overall survival (OS) (HR, 95% CI: 3.40, 1.48‐7.83). The PRO‐C11‐511 biomarker potential was validated in serum from 686 patients with PDAC. Again, high levels of PRO‐C11‐511 (>75th percentile) were associated with poor OS (HR, 95% CI: 1.68, 1.40‐2.02). Furthermore, PRO‐C11‐511 remained significant after adjusting for clinical risk factors (HR, 95% CI: 1.50, 1.22‐1.86). In conclusion, quantifying serum levels of Type XI collagen with PRO‐C11‐511 predicts poor OS in patients with PDAC. This supports that Type XI collagen is important for PDAC biology and that PRO‐C11‐511 has prognostic noninvasive biomarker potential for patients with PDAC.Keywords
This publication has 39 references indexed in Scilit:
- Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controlsBMC Cancer, 2013
- Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic CancerPLOS ONE, 2013
- Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivoBMC Cancer, 2011
- Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related MarkersBiomarkers in Cancer, 2011
- Cancer associated fibroblasts in cancer pathogenesisSeminars in Cell & Developmental Biology, 2010
- Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profilingJournal of Cellular and Molecular Medicine, 2008
- Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblastsArthritis & Rheumatism, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Processing of Type XI CollagenJournal of Biological Chemistry, 1996
- A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cellsSomatic Cell and Molecular Genetics, 1977